about
Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivoMaterial-based deployment enhances efficacy of endothelial progenitor cells.Viability and functionality of cells delivered from peptide conjugated scaffolds.Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.Effects of VEGF temporal and spatial presentation on angiogenesis.Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia.Refilling drug delivery depots through the blood.Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones.Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsTargeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P).Synthetic extracellular matrices for tissue engineering and regeneration.Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.Hydrogel biophysical properties instruct coculture-mediated osteogenic potential.Injectable MMP-sensitive alginate hydrogels as hMSC delivery systems.The Role of Synthetic Extracellular Matrices in Endothelial Progenitor Cell Homing for Treatment of Vascular Disease.Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle.Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications.Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats.Alginate and DNA Gels Are Suitable Delivery Systems for Diabetic Wound Healing.Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis.Alginate hydrogels of varied molecular weight distribution enable sustained release of sphingosine-1-phosphate and promote angiogenesis.Guiding morphogenesis in cell-instructive microgels for therapeutic angiogenesis.Comparison of Endothelial Differentiation Capacities of Human and Rat Adipose-Derived Stem Cells.VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits.Microgels produced using microfluidic on-chip polymer blending for controlled released of VEGF encoding lentivectors.Integrated approach to designing growth factor delivery systems.Tissue engineering: a glue for biomaterials.Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation.Abstract P35: Human Adipose-derived Stem Cells as a Potential Source of Endothelial Cells in Clinical Tissue Engineering Applications.Surface Modification with Alginate-Derived Polymers for Stable, Protein-Repellent, Long-Circulating Gold NanoparticlesAngiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarctionCharacterizing the encapsulation and release of lentivectors and adeno-associated vectors from degradable alginate hydrogelsThaw-Induced Gelation of Alginate Hydrogels for Versatile Delivery of TherapeuticsPositron emission tomography imaging of novel AAV capsids maps rapid brain accumulation
P50
Q27339281-A77B91C8-2CF4-4C45-B8EA-D6C7BE17BEC2Q30484065-9F0E0DAD-B592-4AE4-A340-02AA32C46AD9Q30499428-B56EC89C-D106-4B23-AF9A-76CA53C2DF47Q33517020-C91CBA04-8F94-40A6-B37D-76685E8369DDQ33620964-96C68571-57B8-472B-8FD4-80C9420A65F0Q33779325-374F410B-3EF7-4816-B797-1E8BEC25E149Q34144515-2D30D6AE-B02A-44CE-8F59-7B1F1468EA78Q34241543-AEDE472B-0464-413A-9396-3A874DFEC0C0Q34548765-CDB05A39-9EB0-4233-8B5D-2AD4CEDC0978Q34776009-01841A9B-254C-4D85-97E1-6A1E9B3315E8Q35431408-79A5BB66-F077-4F80-BA8B-AC1A2F680EC1Q35962958-F12BFB6B-E19C-400B-861A-01AAA3FF2ABCQ36330107-1BC5D1F6-A7B1-496F-AE3E-256D1106EAD8Q36385336-D19B7DB1-7F0E-4F1D-B0D3-90B84849C906Q37569930-CB18ED57-3AC4-4F2C-8A41-2F055C61CBC0Q38553350-C30D1F88-41A2-4687-835F-048EE6783CCFQ39122705-F2DFDE12-1BFB-4B8D-B787-00432F0134B7Q39193477-90763671-B9CF-4665-BB0A-99E0D75684C1Q39635049-536B5278-602A-4662-853F-88167FB70774Q41059201-8356EE1B-8D79-4B1A-97B5-9C49C5FC23ECQ43088821-01498331-31F9-4806-8863-C23C804E5161Q45968308-2B2E203C-D8F3-4103-A1E1-F64359FC5DE8Q45979335-31FB73C3-9737-4BBB-A32A-6D4073436824Q46131849-85A32EEF-FAE0-4522-867A-FC3B002E599DQ46487461-AAFA7011-8D13-4D4B-9AA4-622F4F683382Q46830039-6081641E-B275-4D7E-8BFB-3EA07C76744CQ47654763-0DC90FAD-8189-4C6A-B1E5-A7B95B560C73Q49339692-38BC8367-5245-41A9-B090-041C403EA0CFQ50952769-C7A7B0FF-4609-4E13-81D0-83C8F31D478CQ51014761-CC86143F-7DDD-43BE-83AC-439C3DBF5340Q51091121-7634E32B-13D7-48B9-B058-8620DB1DCCA8Q54506841-98BBD1B8-DF06-4065-A89E-5A7D787BA6FDQ57782398-3322E120-788F-4877-AF7D-B9BE88DB9576Q80269916-014D6ECF-2496-4368-A90D-86B433C6C604Q90388751-10EC1341-8483-4E4E-84E8-0053E3DF3359Q91681439-5468307E-7608-436B-B57A-FC2769E1736BQ94474209-08022527-2D02-4EA9-AD60-43D68CBE79CF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eduardo A Silva
@ast
Eduardo A Silva
@en
Eduardo A Silva
@es
Eduardo A Silva
@nl
type
label
Eduardo A Silva
@ast
Eduardo A Silva
@en
Eduardo A Silva
@es
Eduardo A Silva
@nl
prefLabel
Eduardo A Silva
@ast
Eduardo A Silva
@en
Eduardo A Silva
@es
Eduardo A Silva
@nl
P106
P1153
8214120600
P21
P31
P496
0000-0003-3173-7622